Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AERAS-402 in BCG-vaccinated infants
NCT01198366Phase 2Completed
- Sponsor
- Aeras Global Vaccine Foundation
- Start
- Sep 2010
- Primary completion
- Jan 2014
- Modality
- Viral Vector Vaccines
- Countries
- 3
01
Overview
A Phase 2 trial of AERAS-402 in Tuberculosis (TB), sponsored by Aeras Global Vaccine Foundation. Started Sep 2010; status: completed.
02
Drugs
AERAS-402
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01198366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01198366.